Computational Analysis of the Homologous Mouse Double RINGs Interface for Targeted Anticancer Drug Design
Preprint
- 25 August 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The new yearly 1.1 million cancer surges and considerably increasing mortality, post-decades of decline, require urgent and effective therapy. Targeted anticancer therapy is an attractive strategy for treating cancer by targeting critical receptors. Homologous Mouse Double-Minute RINGs (MDM2-MDMX RING) negatively regulate the p53 tumour-suppressing role by promoting proteasomal degradation. Interventively, Hinok., MMRi62, MMRi64, and MMRi71 exert a therapeutic downregulation against MDM2-MDMX RING heterodimer by activating p53’s apoptotic arm, but their binding mechanisms remain poorly understood due to the RING domain’s high structural flexibility and lack of co-crystal structures. This study reveals the underlying dynamic conformational stability and flexibility of the MDM2G443T-MDMX interface, and the potential mechanistic inhibitor binding using the all-atom MD simulations. The MMRi64-bound and Hinok-bound systems exhibited the lowest RMSD values (2.28 Å and 2.34 Å, respectively), indicating significant protein stabilization. MMRi71-bound (1.03 Å) and MMRi64-bound (1.30 Å) complexes displayed the lowest mean RMSF values, demonstrating that these ligands lock the protein into a rigid conformation. Conversely, the MMRi62-bound system showed the highest average RMSD and the highest RMSF (1.74 Å), identifying it as the most flexible complex. The ligand-bound MDM2G443T-MDMX complex underwent notable secondary structure transitions. MMGB/PBSA calculations revealed favorable binding free energies (-22.69, -26.42, and -20.30 kcal/mol) for the key interactions. Arg444, Pro445, Lys473, and Pro476 provided the highest binding free energy contributions to the RING domains. Over the 200 ns simulation, Hinok demonstrated dual interactions with both MDM2G443T-MDMX RING domains, highlighting a potential dual-inhibition mechanism, whereas MMRis interacted selectively with MDM2.Keywords
All Related Versions
- Version 1, 2026-08-25, Preprints
- Published version: Biomedicines, 14 (10), 2366.
This publication has 56 references indexed in Scilit:
- Harunganol-B and beyond: unveiling nature’s arsenal against drug-resistant Acinetobacter baumanniiIn Silico Pharmacology, 2026
- Global Disparities of Cancer and Its Projected Burden in 2050JAMA Network Open, 2024
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Delving into the Characteristic Features of "Menace" Mycobacterium tuberculosis Homologs: A Structural Dynamics and Proteomics PerspectivesThe Protein Journal, 2020
- Dynamic perspectives into the mechanisms of mutation‐induced p53‐DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapyJournal of Cellular Biochemistry, 2018
- Molecular Dynamics Simulations of Ligand‐Induced Flap Conformational Changes in Cathepsin‐D—A Comparative StudyJournal of Cellular Biochemistry, 2016
- Determination of Ensemble-Average Pairwise Root Mean-Square Deviation from Experimental B-FactorsBiophysical Journal, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- MDM2 and MDM4: p53 regulators as targets in anticancer therapyThe International Journal of Biochemistry & Cell Biology, 2007
- Junmei Wang, Romain M. Wolf, James W. Caldwell, Peter A. Kollman, and David A. Case, "Development and testing of a general amber force field"Journal of Computational Chemistry(2004) 25(9) 1157–1174Journal of Computational Chemistry, 2004